Advocacy: Strong foundations

James Mitchell Crow
Additional contact information
James Mitchell Crow: James Mitchell Crow is a freelance science writer based in Melbourne, Australia.

Nature, 2016, vol. 537, issue 7621, S152-S154

Abstract: Most rare diseases lack even one approved treatment. Regulators have tried to encourage drug development, but advocacy groups are having to fight to get the research done.

Date: 2016
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/537S152a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:537:y:2016:i:7621:d:10.1038_537s152a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/537S152a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().